Prevalence of SARS-CoV-2-specific antibodies in a sample of the Lithuanian population-based study in Spring 2023

Prevalence of SARS-CoV-2-specific antibodies in a sample of the Lithuanian population-based study in Spring 2023

Objectives: Despite positive trends in SARS-CoV-2 epidemiology, seroprevalence surveys remain an important tool for estimating the magnitude of the COVID-19 pandemic. This study aimed to investigate the prevalence of IgG antibodies against SARS-CoV-2 nucleocapsid (N) and spike (S) proteins in a samp...

Full description

Bibliographic Details
Main Authors: Martynas Simanavičius, Indrė Kučinskaitė-Kodzė, Snieguolė Kaselienė, Skirmantė Sauliūnė, Dainius Gudas, Ligita Jančorienė, Rūta Jasinskienė, Astra Vitkauskienė, Rasa Žūtautienė, Aurelija Žvirblienė, Mindaugas Stankūnas
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Heliyon
Subjects:
COVID-19
SARS-CoV-2
Lithuania
Anti-N IgG
Seroprevalence
Online Access:http://www.sciencedirect.com/science/article/pii/S240584402405374X

Internet

http://www.sciencedirect.com/science/article/pii/S240584402405374X

Similar Items